Press release
18.10.2023 To the attention of interested persons EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens […]
Important notification
16.10.2023 To the attention of interested persons Notification concerning professional training and instruction courses for staff with specific duties of […]
Press release
06.10.2023 To the attention of interested persons Revised transparency rules for the EU Clinical Trials Information System (CTIS) download document […]
Important notification
06.10.2023 To the attention of manufacturers, authorised representatives, economic operators and all interested parties Please be informed that on 27 […]
Important notification
04.10.2023 To the attention of manufacturers, authorised representatives, economic operators and all interested parties We hereby inform you that on […]
Important notification
02.10.2023 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
27.09.2023 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Press release
26.09.2023 To the attention of interested persons The Ministry of Health and the National Agency for Medicines and Medical Devices […]
Important notification
25.09.2023 To the attention of all stakeholders (importers/distributors, users) Following a notification received and the checks carried out by the […]
Press release
14.09.2023 To the attention of interested persons Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 download document […]